Fintel reports that on July 2, 2025, Compass Point downgraded their outlook for Strawberry Fields REIT (NYSEAM:STRW) from Buy ...

Fintel reports that on July 2, 2025, Compass Point initiated coverage of Block (NYSE:XYZ) with a Buy recommendation. Analyst ...

Robinhood's crypto-focused keynote may be an opportunity for investors to buy the dip, investment bank Compass Point signaled ...

Investing.com -- Compass Point has initiated coverage on Circle Internet Group Inc . (NYSE:CRCL) with a “neutral” rating and a $205 price target, citing both its leadership in regulated ...

Compass Pathways plc downgraded to Hold after mixed trial results. Explore upcoming catalysts in depression treatment and ...

Compass Pathways' Phase 3 COMP-360 data met primary endpoints but disappointed vs analyst expectations. See why investors ...

Investing.com -- Compass Point has initiated coverage on Circle Internet Group Inc . (NYSE:CRCL) with a “neutral” rating and a $205 price target, citing both its leadership in regulated stablecoins ...

CRCL shares trade at more than 100 times EBITDA, reflecting bullish long-term assumptions. Compass Point projects stablecoins could capture 10% of U.S. M2 money supply by 2030, translating to a $2 ...

CRCL (LON:CRCL) shares trade at more than 100 times EBITDA, reflecting bullish long-term assumptions. Compass Point projects stablecoins could capture 10% of U.S. M2 money supply by 2030, translating ...

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

Compass Pathways took a 50% on June 23 hit after a lukewarm trial, but long-term bulls see upside in psychedelics.

Compass Point believes sufficient catalysts remain in 2025 that could drive the stock higher. The new $96 price target reflects a higher multiple applied to Compass Point’s 2026 EBITDA estimate ...